← Back to Search

Behavioral Intervention

iExposure for Social Anxiety

N/A
Recruiting
Research Sponsored by Palo Alto University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 or older
Be older than 18 years old
Must not have
Current or past bipolar disorder or psychosis
Currently receiving CBT for Social Anxiety Disorder
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 45 days
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to improve treatment for social anxiety, a common mental health issue. Many young people are affected, but few receive proper care due to limited access to effective treatments. The COVID-19 pandemic

Who is the study for?
This trial is for adults over 18 who speak English and score higher than 47 on the Leibowitz Social Anxiety Scale, indicating they have social anxiety. They must also endorse social anxiety items on a specific web questionnaire.
What is being tested?
The study tests iExposure therapy for social anxiety by comparing standard treatment to two variations: one with attention guidance and another with attention control, aiming to optimize treatment effectiveness.
What are the potential side effects?
As this is a psychological intervention focusing on exposure therapy, side effects may include temporary increases in anxiety or discomfort during the process of facing feared social situations.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have or had bipolar disorder or psychosis.
Select...
I am currently undergoing cognitive behavioral therapy for social anxiety.
Select...
My mental health medication dose has been stable for the last 6 weeks.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~45 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 45 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Liebowitz Social Anxiety Scale Self Report Version
Personal Report of Communication Apprehension
Personal Report of Communication Apprehension (PRCA)
Secondary study objectives
Center for Epidemiologic Studies Depression Scale - Revised

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: iExposure + Attention Guidance AugmentationExperimental Treatment1 Intervention
Attention Guidance Augmentation. The attention guidance condition consists of two unique components in addition to the standard iExposure intervention: (1) the intervention rationale will include information about the importance of visually attending to the faces of the audience; (2) participants will be given a target audience member to focus their gaze on during each impromptu response. They will be told that they should look at and focus on the target audience member for the whole response. In each progressive session the number of trials where the participant is directed to focus on an uninterested audience member will increase.
Group II: iExposure + Attention Control AugmentationExperimental Treatment1 Intervention
The attention control condition consists of two unique components in addition to the standard iExposure intervention (1) the intervention rationale will include information about the importance of developing attention control; (2) participants will be given a central region of the screen (non-audience member) to focus on. They will be told that they should look at and focus on the central region for the whole response.
Group III: Standard iExposureActive Control1 Intervention
iExposure. Participants will complete four intervention sessions within two weeks. The intervention will use an entirely self-guided protocol delivered via Qualtrics and Gorilla Experiment Builder: 1. During the first session, participants will receive a brief standardized psychoeducation module, presented via a 15-minute video recording. This video will explain the intervention, its rationale, and the procedure. 2. Participants will then complete 10 simulated teleconferencing interaction trials with different topics, each lasting a maximum of two minutes. During each call participants will be prompted by one of the audience members to respond to a question (described in further detail in the Materials section, below). 3. Participants will complete the Subjective Units of Distress Scale before and after each speech trial. 4. Sessions 2-4 involve the same protocol and the four intervention sessions are completed within two weeks.

Find a Location

Who is running the clinical trial?

Palo Alto UniversityLead Sponsor
13 Previous Clinical Trials
7,705 Total Patients Enrolled
~260 spots leftby Jun 2026